SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

VTGN

VistaGen Therapeutics Inc.
NASDAQHealth Care

Latest close: 0.26 USD · Aug 26, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 25, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 24, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year172
SEC filings on record86321 flagged findings
Reported transactions (Form 4)62since Dec 30, 2022 · and 4 other holdings
Corporate events (8-K)30since Jul 8, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-15share offering or dilution eventrecentOpen filing ↗
    “…non-cash acquisitions of product licenses, the Pherin Acquisition, and in settlements of certain liabilities, including liabilities…”
    +1 more passage from the same document
    • “…giving effect to the exercise. However, any holder may increase or decrease such percentage to any other percentage (not to exceed…”
  • 2026-06-15listing compliance noticerecentOpen filing ↗
    “…we were not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued…”
    +1 more passage from the same document
    • “…could be 72 Table of Contents negatively impacted. Moreover, there can be no assurance that we will be able to regain compliance…”
  • 2026-06-15capital return (buybacks/dividends)recentOpen filing ↗
    “…should be classified as equity instruments within additional paid-in capital. The Pre-Funded Warrants are equity classified because…”
    +1 more passage from the same document
    • “…fair market value on the date of exercise over the grant price of the SAR. The Compensation Committee may also grant awards of…”
  • 2026-06-15Department of Justice inquiryrecentOpen filing ↗
    “…including but not limited to research, sales, promotion, marketing, distribution, medical education, sponsorships, relationships…”
  • 2026-06-15merger or acquisition eventrecentOpen filing ↗
    “…the Company’s Current Report on Form 8-K filed on May 14, 2021. 1.2 Underwriting Agreement, dated as of October 2, 2023, by and among…”
    +1 more passage from the same document
    • “…Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and William Blair & Company, L.L.C., incorporated by reference from…”
  • 2026-06-15reverse splitrecentOpen filing ↗
    “…per share for a minimum of 10 consecutive business days. An additional 180 days may be granted to regain compliance, so long as we…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Aug 5, 2026).

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:30 on Jun 7, 2023) · 1:30 cumulative

The other times: of 785 securities that did their first reverse split in 5 years, a year later the median was worth 0.54× the price on the day of the split; 364 lost more than half and 204 rose (783 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 863)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 25, 268-K ↗Current report · Communication to the market
  • Sep 24, 268-K ↗Current report · Other events
  • Sep 22, 268-K ↗Current report · Other events
  • Sep 11, 268-K ↗Current report · Shareholder vote results
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Commodore Capital LP · 9.9% · event on Jun 30, 26 · amendment
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 268-K ↗Current report · Results
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Chen Yu · 6.7% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • Aug 6, 268-K ↗Current report · Communication to the market · Other events
  • Aug 5, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Jul 31, 26Form 4 ↗Insider transaction
  • Jul 31, 26Form 3 ↗Insider transaction
  • Jul 31, 26DEFA14A ↗Shareholder meeting and votes
  • Jul 31, 26DEF 14A ↗Shareholder meeting and votes
  • Jul 31, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Jun 30, 268-K ↗Current report · Communication to the market · Other events
  • Jun 17, 268-K ↗Current report · A senior executive left or was appointed
  • Jun 15, 2610-K ↗Annual report
  • Jun 15, 268-K ↗Current report · Results
  • Jun 9, 268-K ↗Current report · Other events

863 filings on record, the oldest from Jul 31, 08.

Listing the 25 most recent filings of the 863 on record.

8-Ks, explained

Stress10Structure88Governance36
  • Oct 9, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 5, 26StressListing notice (8-K 3.01)nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Governance4 senior executive changes2026show all 4hide
    • Jul 31, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 17, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 19, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Apr 13, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 2, 26StressListing notice (8-K 3.01)nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Mar 18, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 20, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 6, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Governance4 senior executive changes2025show all 4hide
    • Dec 3, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Oct 29, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 15, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 25, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 12, 24GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Oct 26, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Oct 4, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Sep 8, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗

12 older filings not shown · The record reaches back to May 16, 11.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Mar 7, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Sep 7, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 13, 20StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Apr 3, 20StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Jan 31, 20StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Aug 23, 19StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 21, 19StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗

The full record holds 10 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Commodore Capital LP9.9%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Chen Yu6.7%Jun 30, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Great Point Partners, LLC5.0%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Nantahala Capital Management, LLC4.7%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • The Vanguard Group4.6%Dec 31, 25SCHEDULE 13G/A ↗1 earlier filing
show 2 more holdershide
  • ORBIMED CAPITAL LLC4.2%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • StemPoint Capital LP1.5%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 7, 23Buy$18.0MCOMMODORE CAPITAL LP↗
Stock compensation, tax and giftsshow the 21 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 30, 26Compensation$7KShawn SinghPresident and CEO↗
  • Jun 30, 26Compensation$2KNick B. TresslerChief Financial Officer↗
  • Jun 30, 26Compensation$7KReid G. AdlerChief Legal Officer↗
  • Dec 31, 25Compensation$2KJoshua S. PrinceChief Operating Officer↗
  • Jun 30, 25Compensation$13KShawn SinghPresident and CEO↗
  • Jun 30, 25Compensation$11KCynthia Lynn AndersonCHIEF FINANCIAL OFFICER↗
  • Jun 30, 25Compensation$13KReid G. AdlerChief Legal Officer↗
  • Jun 30, 25Compensation$8KJoshua S. PrinceChief Operating Officer↗
  • Dec 31, 24Compensation$6KCynthia Lynn AndersonCHIEF FINANCIAL OFFICER↗
  • Dec 31, 24Compensation$8KJoshua S. PrinceChief Operating Officer↗
  • Jun 28, 24Compensation$14KShawn SinghCHIEF EXECUTIVE OFFICER↗
  • Jun 28, 24Compensation$14KReid G. AdlerCHF CORP DEVEL OFF, GEN COUNS↗
  • Jun 28, 24Compensation$11KCynthia Lynn AndersonCHIEF FINANCIAL OFFICER↗
  • Jun 28, 24Compensation$8KJoshua S. PrinceChief Operating Officer↗
  • Dec 29, 23Compensation$287Shawn SinghCHIEF EXECUTIVE OFFICER↗
  • Dec 29, 23Compensation$287Reid G. AdlerCHF CORP DEVEL OFF, GEN COUNS↗
  • Jun 30, 23Compensation$265JERROLD DUANE DOTSONVP, CFO↗
  • Jun 30, 23Compensation$265Reid G. AdlerCHIEF LEGAL OFFICER↗
  • Jun 30, 23Compensation$265Shawn SinghCHIEF EXECUTIVE OFFICER↗
  • Dec 30, 22Compensation$438Shawn SinghCHIEF EXECUTIVE OFFICER↗
  • Dec 30, 22Compensation$438JERROLD DUANE DOTSONVP, CFO AND SECRETARY↗

The full record holds 22 transactions and goes back to Dec 30, 22.

Its sector and its market

VistaGen Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From VistaGen Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow VistaGen Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
863 documents on file, from Jul 31, 2008 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.